A
AVIPERO
avipero.co.uk
Website unreachable since Oct 25, 2026
AVIPERO is developing allosteric modulators of integrins to enhance tissue repair and address age-related diseases. Their technology targets integrin pathways to improve healing processes and mitigate the effects of aging on tissue function.
- Biotechnology
Updated 7 months ago
Funding
Funding rounds are not available yet.
Founders
Product
Features
- AVIPERO is developing allosteric modulators of integrins to enhance tissue repair and address age-related diseases. Their technology targets integrin pathways to improve healing processes and mitigate the effects of aging on tissue function.